20.30
Finanzdaten der Mineralys Therapeutics Inc-Aktie (MLYS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
442.66%
246.04
|
45.34 | 38.28 | 41.13 | 46.75 |
| Operating Income/Loss |
442.66%
-246.04
|
-45.34 | -38.28 | -41.13 | -46.75 |
| Nonoperating Income/Loss |
17.20%
4.969
|
6.001 | 6.046 | 4.199 | 3.472 |
| Net Income/Loss |
512.80%
-241.07
|
-39.34 | -32.23 | -36.93 | -43.27 |
| Basic Average Shares |
2.28%
84.73
|
82.83 | - | 70.59 | 65.45 |
| Diluted Average Shares |
2.28%
84.73
|
82.83 | - | 70.59 | 65.45 |
| Basic Earnings Per Share |
506.38%
-2.85
|
-0.47 | - | -0.52 | -0.66 |
| Diluted Earnings Per Share |
506.38%
-2.85
|
-0.47 | - | -0.52 | -0.66 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):